Immunotherapy for Alzheimer's disease: will vaccination work?

被引：20

作者：

Dodart, JC ^{[1
]}

Bales, KR ^{[1
]}

Paul, SM ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA

来源：

TRENDS IN MOLECULAR MEDICINE | 2003年 / 9卷 / 03期

关键词：

D O I：

10.1016/S1471-4914(03)00022-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Active or passive immunization against the beta-amyloid peptide (Abeta) has been proposed as a method for preventing and/or treating Alzheimer's disease (AD). In addition to lowering brain Abeta and amyloid burden in transgenic mouse models of AD, a beneficial effect of immunization on previously characterized memory impairment(s) has also been reported in these mice. Whether these preclinical data will predict efficacy in AD patients remains to be seen. A clinical trial of active immunization (vaccination) was halted, owing to a serious adverse event (meningoencephalitis), raising questions about the safety of this approach. Two recent reports suggest that immunotherapy-based approaches to treating and preventing AD will require careful antigen and antibody selection, to maximize efficacy and minimize serious adverse events. However, given the potential efficacy of this approach, we believe that immunotherapy for AD should not be prematurely abandoned.

引用

页码：85 / 87

页数：3

共 21 条

[1] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].

Bard, F ;

Cannon, C ;

Barbour, R ;

Burke, RL ;

Games, D ;

Grajeda, H ;

Guido, T ;

Hu, K ;

Huang, JP ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, M ;

Lieberburg, I ;

Motter, R ;

Nguyen, M ;

Soriano, F ;

Vasquez, N ;

Weiss, K ;

Welch, B ;

Seubert, P ;

Schenk, D ;

Yednock, T .

NATURE MEDICINE, 2000, 6 (08) :916-919

[2] Nerve inflammation halts trial for Alzheimer's drug [J].

Check, E .

NATURE, 2002, 415 (6871) :462-462

[3] Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease [J].

DeMattos, RB ;

Bales, KR ;

Cummins, DJ ;

Dodart, JC ;

Paul, SM ;

Holtzman, DM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8850-8855

[4] Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease [J].

DeMattos, RB ;

Bales, KR ;

Cummins, DJ ;

Paul, SM ;

Holtzman, DM .

SCIENCE, 2002, 295 (5563) :2264-2267

[5] Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model [J].

Dodart, JC ;

Bales, KR ;

Gannon, KS ;

Greene, SJ ;

DeMattos, RB ;

Mathis, C ;

DeLong, CA ;

Wu, S ;

Wu, X ;

Holtzman, DM ;

Paul, SM .

NATURE NEUROSCIENCE, 2002, 5 (05) :452-457

[6] Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease [J].

Hock, C ;

Konietzko, U ;

Papassotiropoulos, A ;

Wollmer, A ;

Streffer, J ;

von Rotz, RC ;

Davey, G ;

Moritz, E ;

Nitsch, RM .

NATURE MEDICINE, 2002, 8 (11) :1270-1275

[7] Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease [J].

Janus, C ;

Pearson, J ;

McLaurin, J ;

Mathews, PM ;

Jiang, Y ;

Schmidt, SD ;

Chishti, MA ;

Horne, P ;

Heslin, D ;

French, J ;

Mount, HTJ ;

Nixon, RA ;

Mercken, M ;

Bergeron, C ;

Fraser, PE ;

St George-Hyslop, P ;

Westaway, D .

NATURE, 2000, 408 (6815) :979-982

[8] APP transgenic mice Tg2576 accumulate Aβ peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques [J].

Kalback, W ;

Watson, MD ;

Kokjohn, TA ;

Kuo, YM ;

Weiss, N ;

Luehrs, DC ;

Lopez, J ;

Brune, D ;

Sisodia, SS ;

Staufenbiel, M ;

Emmerling, M ;

Roher, AE .

BIOCHEMISTRY, 2002, 41 (03) :922-928

[9] Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4-10 and inhibit cytotoxicity and fibrillogenesis [J].

McLaurin, J ;

Cecal, R ;

Kierstead, ME ;

Tian, X ;

Phinney, AL ;

Manea, M ;

French, JE ;

Lambermon, MHL ;

Darabie, AA ;

Brown, ME ;

Janus, C ;

Chishti, MA ;

Horne, P ;

Westaway, D ;

Fraser, PE ;

Mount, HTJ ;

Przybylski, M ;

St George-Hyslop, P .

NATURE MEDICINE, 2002, 8 (11) :1263-1269

[10] Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease [J].

Morgan, D ;

Diamond, DM ;

Gottschall, PE ;

Ugen, KE ;

Dickey, C ;

Hardy, J ;

Duff, K ;

Jantzen, P ;

DiCarlo, G ;

Wilcock, D ;

Connor, K ;

Hatcher, J ;

Hope, C ;

Gordon, M ;

Arendash, GW .

NATURE, 2000, 408 (6815) :982-985

← 1 2 3 →